| Financial Year |
March 31 2023 |
| Monetary Funds |
875,447,771.32 |
| Held-for-trading Financial Assets |
280,930,550.16 |
| Notes Receivable |
-- |
| Accounts Receivable |
189,818,137.56 |
| Advances to Suppliers |
23,597,189.70 |
| Other Receivables |
15,117,577.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
174,473,816.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,713,722.99 |
| Total Current Assets |
1,646,363,602.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,302,583.92 |
| Investment Properties |
29,865,339.71 |
| Fixed Assetes |
142,905,422.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
91,100,910.31 |
| R&D expenses |
-- |
| Goodwill |
7,291,542.22 |
| Long-Term Deferred and Prepaid Expenses |
7,396,068.82 |
| Deferred Income Tax Assets |
10,318,476.18 |
| Other Non-Current Assets |
302,420,800.20 |
| Sub-Total of Non-Current Assets |
710,960,942.71 |
| Total Assets |
2,357,324,545.37 |
| Short-Term Loans |
9,776,954.91 |
| Trading Financial liabilities |
2,029,990.00 |
| Notes Payable |
46,849,751.03 |
| Accounts Payable |
158,793,246.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,856,854.06 |
| Taxes Payable |
18,213,687.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,633,877.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,783,452.12 |
| Other Current Liabilities |
3,242,329.03 |
| Sub-Total of Current Liabilities |
344,496,362.72 |
| Long-term Loans |
204,769,366.14 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,417,933.67 |
| Deferred Income Tax Liabilities |
1,572,846.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
266,096,436.76 |
| Total Liabilities |
610,592,799.48 |
| Paid-In Capital(Or Share Stock) |
455,843,200.00 |
| Capital Surplus |
741,522,306.00 |
| Surplus Reserve |
124,087,190.13 |
| LESS:Treasury Stock |
29,306,674.46 |
| Undistributed Profits |
381,549,019.02 |
| Minority Stockholder's Interest |
48,838,265.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,697,893,480.36 |
| Owner's Equity（Stockholder's Equity） |
1,746,731,745.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,357,324,545.37 |
